← Back to Meds

Pilocarpine hydrochloride 0.4%

Glaucoma · Rx
RxGlaucomaGlaucoma CholPreservative-free option Dark green cap
Strength0.4%
Typical quantity30 x 0.4 mL vials (30-day)
Cash cost / month Moderate · ~$20-100
Drug classCholinergic (muscarinic) agonist / miotic, presbyopia formulation
Mechanism of actionDirect muscarinic agonist; contracts the iris sphincter for a pinhole (miotic) effect that extends depth of focus for near vision. Lower concentration than Vuity (1.25%), formulated with dual lubricants (hyaluronic acid + HPMC) for comfort.
Indication / reason for usePresbyopia. A distinct product from Vuity, not indicated for glaucoma or angle-closure.
Usual adult dosing1 drop each eye, once or twice daily as needed. Onset ~20 min, duration up to ~8 h.
PreservativePreservative-free, single-use vials , a preservative-free option exists
Contact lensesRemove lenses; reinsert after 15 minutes.
Common / important adverse effectsBrow ache / accommodative spasm, dim vision at night (miosis), headache, eye redness; the usual miotic cautions apply at higher doses, but are minimal at this low concentration.
Contraindications & cautionsConditions where miosis is undesirable (e.g. acute uveitis); the same relative cautions as other miotics for peripheral retinal disease.
Pregnancy / lactationLimited data; use only if clearly needed.
Pregnancy category (older labels)No letter category on the current label. From DailyMed labels, checked Nov 2026.
Trade namesQlosi
Practice notesFDA-approved October 2023 (NEAR-1/NEAR-2 trials), available in the US since April 2025. A second FDA-approved presbyopia drop, competing directly with Vuity (1.25% pilocarpine, once daily).
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.

Open in the full tool →